Understanding how a natural substance helps eye stem cells and how this could lead to new treatments
Hyaluronan in the limbal stem cell niche: from regulation of stem cell fate to translational applications
This project explores how a natural substance in your eye helps maintain special stem cells that keep your cornea healthy, aiming to find new ways to treat eye conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11047905 on NIH RePORTER |
What this research studies
Our eyes have special stem cells at the edge of the cornea, called limbal stem cells, which are crucial for keeping the front surface of the eye healthy and repairing it after injury. This project focuses on a natural substance called hyaluronan (HA) that surrounds these stem cells and appears essential for their proper function. We want to understand exactly how HA helps these stem cells stay active and prevent them from changing into other cell types too soon. By learning more about this process, we hope to develop new ways to encourage the eye's natural healing abilities, especially after corneal damage.
Who could benefit from this research
Good fit: This research is foundational for patients experiencing corneal injuries, limbal stem cell deficiency, or other conditions that affect the health of the eye's surface.
Not a fit: Patients seeking immediate treatment options may not directly benefit from this early-stage foundational research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that help repair corneal damage and prevent blindness by supporting the eye's natural stem cells.
How similar studies have performed: This project builds on the research team's previous findings about hyaluronan's role in eye stem cell health, exploring new, specific mechanisms.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Coulson-Thomas, Vivien Jane — University of Houston
- Study coordinator: Coulson-Thomas, Vivien Jane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.